Author

S. Tosi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Bioengineering· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Research Focus:cell signaling & trafficking· 2 Organism:human· 2 Assay:imaging· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

J. Colombelli· 2 shared A. Abad-Lazaro· 1 shared A. C. Hernandez· 1 shared A. G. Duran· 1 shared A. Llado· 1 shared A. Llebaria· 1 shared A. Nezu· 1 shared A. Sala· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. Colombelli

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

DLG1 functions upstream of SDCCAG3 and IFT20 to control ciliary targeting of polycystin-2

C. K. Rezi, M. Aslanyan, G. D. Diwan, T. Cheng, M. Chamlali, K. Junger, Z. Anvarian, e. lorentzen, K. B. Pauly, Y. Bahadori, E. F. Fernandes, F. Qian, S. Tosi, S. T. Christensen, S. F. Pedersen, , L. B. Pedersen

This study shows DLG1 regulates ciliary protein trafficking in kidney cells, with loss of DLG1 causing ciliary elongation and cysts, and a specific DLG1 variant linked to kidney disease.

bioRxiv · Nov 10, 2023Cell Biology

Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles

D. Ragusa, Y. Ciciro, C. Federico, S. Saccone, F. Bruno, R. Saeedi, C. Sisu, C. Pina, A. Sala, S. Tosi

This study creates a t(7;12) AML model in K562 cells that mirrors patient-specific gene expression and features, aiding in understanding disease mechanisms.

bioRxiv · Jun 14, 2022Cancer Biology

Modelling biochemical gradients in vitro to control cell compartmentalization in a microengineered 3D model of the intestinal epithelium

G. Altay, A. Abad-Lazaro, E. J. Gualda, J. Folch, C. Insa, S. Tosi, X. Hernando-Momblona, E. Batlle, P. Loza, V. Fernandez-Majada, E. Martinez

The paper develops a 3D in vitro intestinal model with controlled biochemical gradients to study cell compartmentalization and its response to niche factors.

bioRxiv · Dec 13, 2021Bioengineering

Drs2 regulates TRAPPIII in Atg9 transport: exposing the interplay of P4-ATPases and Multisubunit Tethering Complexes

I. Pazos, M. Puig-Tinto, J. Cordero, N. Jimenez-Menendez, M. Abella, A. G. Duran, E. Adachi-Fernandez, C. Belmonte-Mateos, S. Sabido-Bozo, A. C. Hernandez, S. Tosi, A. Nezu, J. Colombelli, T. R. Graham, T. Yoshimori, , O. Gallego

The paper investigates how Drs2 interacts with TRAPPIII to regulate Atg9 transport during selective autophagy, revealing a novel role for P4-ATPases in this process.

bioRxiv · Dec 25, 2020Cell Biology

Reversible silencing of endogenous receptors in intact brain tissue using two-photon pharmacology

S. Pittolo, H. Lee, A. Llado, S. Tosi, M. Bosch, L. Bardia, X. Gomez-Santacana, A. Llebaria, E. Soriano, J. Colombelli, K. E. Poskanzer, G. Perea, P. Gorostiza

This paper introduces two-photon pharmacology to reversibly silence mGlu5 receptors in intact brain tissue, enabling study of synaptic and signaling processes.

bioRxiv · Jan 10, 2019Pharmacology & Toxicology